Your browser does not support Javascript
email@mymsaa.org
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Register Why Register Contact MSAA Site Preferences Print Page Home
Improving Lives Today!
Donate Button
The Motivator iconMSAA's MAGAZINE
The Motivator
Booklets and Brochures iconBooklets & Brochures
MS Research Update 2014
MS Research Update 2013
The Affordable Care Act
and Multiple Sclerosis
How to S.E.A.R.C.H.™ for the Right
MS Therapy for You!
Understanding and Treating
MS Relapses
Solutions for Wellness: A Guide to
MSAA's Programs and Services -
Second Edition
The Multiple Sclerosis Association
of America Programs & Services
Guide in Spanish
Mommy's Story
Daddy's Story
Understanding and Treating
Depression in Multiple Sclerosis
MSAA Monograph: Thinking about
Complementary and Alternative
Medicine?
MSAA Monograph: The Confusing
World of Clinical Trials
Multiple Sclerosis and Cooling
(3rd edition)
Primary Progressive Multiple
Sclerosis: What You Need to Know
Order Publications iconOrder Publications
Individual Order
Group Orders



Home > MSAA Publications > The Motivator > The Motivator: Winter/Spring 2009 > Cover Story - Symptom Management Update > SECTION 15: VISION

< SECTION 14: SPEECH & SWALLOWING - Home - SECTION 16: SEXUALITY >

SECTION 15: VISION

Visual difficulties are common in MS. The most common problems are decreased or blurred vision (optic neuritis), double vision (diplopia) and what is termed, "involuntary movements of the eyes" (nystagmus). All are the result of MS lesions in areas of the brain that control and coordinate vision.

Optic neuritis is an inflammation of the optic nerve, which - unlike the nerves that innervate most of the body, which are part of the peripheral nervous system - is actually a part of the central nervous system and is myelinated in the same way as axons in the brain and spinal cord. Many individuals experience optic neuritis as their first symptom of MS.

Double vision and involuntary eye movements are the result of lesions in the brain stem, a part of the nervous system between the brain and cervical spinal cord.

Because these conditions are all the result of MS inflammation and myelin damage, treatment is generally the same for all three.

NON-PHARMACOLOGIC MANAGEMENT

Like other MS exacerbations, it is often sufficient to take a "wait and see" attitude; these problems often resolve on their own, after the attack or relapse has subsided. With certain visual problems, prisms in eye glasses may help some patients.

PHARMACOLOGIC MANAGEMENT

Very High-Dose Steroids

The same steroid treatment used to treat other types of MS relapses is often effective in shortening the duration of visual problems. These are usually given via IV for a few days, but steroids may also be given orally. An example of a "very" high dose of steroids would be 1,000 mg of Solu-Medrol®(IV methylprednisolone).

MS Disease-Modifying Therapies

Mentioned earlier, six disease-modifying therapies favorably reorganize the immune system and are currently approved for treating the relapsing forms of MS. Several studies have shown that these can reduce the number and severity of attacks, which in turn reduces the development of visual difficulties.

Low-Vision Management

If visual problems persist, an ophthalmologist who specializes in low vision can help provide low-vision devices that include magnification and computer modifications. He or she can also design a variety of helpful strategies for managing daily activities.

< SECTION 14: SPEECH & SWALLOWING - Home - SECTION 16: SEXUALITY >

Last Updated on Friday, 10 May 2013 10:16